| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/04/2009 | EP1546150B1 Pyrrole derivatives as inhibitors of cyteine proteases |
| 03/04/2009 | EP1499736B1 Improved chimeric glycoproteins and pseudotyped lentiviral vectors |
| 03/04/2009 | EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 03/04/2009 | EP1472209B1 Lipoxin a4 analogs |
| 03/04/2009 | EP1463758B1 Mammalian prolactin variants |
| 03/04/2009 | EP1455785B1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 03/04/2009 | EP1453507B1 Solubilized topoisomerase poison agents |
| 03/04/2009 | EP1452527B1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation |
| 03/04/2009 | EP1427720B1 3-substituted-4-pyrimidone derivatives |
| 03/04/2009 | EP1414494B1 Inhibitory antibodies of her3 activity |
| 03/04/2009 | EP1401863B1 Somatostatin-dopamine chimeric analogs |
| 03/04/2009 | EP1294876B1 Eg-vegf nucleic acids and polypeptides and methods of use |
| 03/04/2009 | EP1255845B1 Modified cytokines for use in cancer therapy |
| 03/04/2009 | EP1252322B2 Herpes virus strains for gene therapy |
| 03/04/2009 | EP1246917B1 Human stra6 polypeptides |
| 03/04/2009 | EP1181366B1 Mammalian receptor proteins; related reagents and methods |
| 03/04/2009 | EP1123099B1 Novel indenoisoquinolines as antineoplastic agents |
| 03/04/2009 | EP1045861B1 Bispecific targeting moiety comprising an antibody to carcinoembryonic antigen (cea) and the ligand-binding region of the il13 receptor alpha subunit |
| 03/04/2009 | CN101379192A Anti-Met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products |
| 03/04/2009 | CN101379089A Anti-ILT7 antibody |
| 03/04/2009 | CN101379061A Inhibitors of E1 activating enzyme |
| 03/04/2009 | CN101379060A Benzazole derivatives, compositions, and methods of use as Aurora kinase inhibitors |
| 03/04/2009 | CN101379059A N-hydroxyacrylamide compounds |
| 03/04/2009 | CN101379058A Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases |
| 03/04/2009 | CN101379056A Compounds for the inhibition of integrins and use thereof |
| 03/04/2009 | CN101379046A Processes for taxane derivatives and intermediates useful therein |
| 03/04/2009 | CN101378770A Use of local immune suppression to enhance oncolytic viral therapy |
| 03/04/2009 | CN101378751A Tuberous sclerosis treatment |
| 03/04/2009 | CN101378744A Oxadiazole compounds as urokinase inhibitors |
| 03/04/2009 | CN101377487A Application of human transcription co-activate factor PC4 in preparations for preparing, diagnosing, curing or preventing tumor |
| 03/04/2009 | CN101376904A Intra-polysaccharides from mycelia of ganoderma sinensis, and preparation and use thereof |
| 03/04/2009 | CN101376671A Novel antineoplastic compound Ananaside B in sea cucumber |
| 03/04/2009 | CN101376670A Novel antineoplastic compound Ananaside C in sea cucumber |
| 03/04/2009 | CN101376659A Method for purifying camptothecine and derivative thereof |
| 03/04/2009 | CN101376658A 7-position cycloalkyl substituted camptothecine derivative, synthetic method and use thereof |
| 03/04/2009 | CN101376021A Application of recombinant human interferon gamma in preparing medicament for treating tumor |
| 03/04/2009 | CN101375954A Medicament composition, preparation method thereof and use |
| 03/04/2009 | CN101375938A Cudrania tricuspidata extract, preparation and application thereof |
| 03/04/2009 | CN101375937A Cudrania tricuspidata extract, preparation and application thereof |
| 03/04/2009 | CN101375936A Anti-tumor compound cherimoya formulation and preparation method thereof |
| 03/04/2009 | CN101375915A Preparation of Rhodiola rosea glycosides and application thereof in medicine field |
| 03/04/2009 | CN101375868A Technique for extracting pine and cypress vigor element from branches and leaves, roots and barks, and flower bulbs of pine and cypress |
| 03/04/2009 | CN101375863A Method for extracting polysaccharide and other multiple active components in boiling juice of trepang |
| 03/04/2009 | CN101375862A Preparation of total saponins of Thelenota ananas and application thereof in medicine field |
| 03/04/2009 | CN101375860A Application of cisplatin combined with hTERT-HRP/IAA in medicament for treating cervical cancer cell |
| 03/04/2009 | CN101375846A Ellagic acid supermolecule composition and preparation method |
| 03/04/2009 | CN101375839A Grifola frondosa polysaccharide soft capsules and preparation method thereof |
| 03/04/2009 | CN100465188C Novel antibiotic Chemomycin B, C, D and a preparation method thereof |
| 03/04/2009 | CN100465187C Upright datura flower steroid-lactone components, and a preparation and a pharmaceutical in antitumour medicines |
| 03/04/2009 | CN100465177C An oxygen, nitrogen heterocyclic naphthoyl imine kind compound and a biological application thereof |
| 03/04/2009 | CN100465175C A 7-bit substituted comptothecine kind compound and a pharmaceutical use thereof |
| 03/04/2009 | CN100464789C A digestive tract stent with anti-cancer medicinal particles |
| 03/04/2009 | CN100464785C An anti-cancer drug slow release injection and an application thereof |
| 03/04/2009 | CN100464783C An anti-cancer medicine composition with anti-neoplastic antibiotics |
| 03/04/2009 | CN100464759C Anticancer Chinese traditional extracts and a preparation process and an application thereof |
| 03/04/2009 | CN100464744C An orally disintegrated Ubenimex tablet and a preparation method thereof |
| 03/04/2009 | CN100464740C An osmotic pump controlled release tablet of solid dispersion of hydroxy camptothecin and a preparation method thereof |
| 03/04/2009 | CN100464737C A medicinal composition of nimustine and a synergist thereof |
| 03/04/2009 | CN100464736C A slow released anticancer injection with both antimetabolite and a synergist thereof |
| 03/03/2009 | US7498420 Human monoclonal antibody for use in the diagnosis prevention and treatment of cell proliferative disorders; immunotherapy; immunodiagnostics |
| 03/03/2009 | US7498417 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy |
| 03/03/2009 | US7498416 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 03/03/2009 | US7498415 Culturing, gene expression, transformation; fab and fv fragments; biodrugs; anticarcinogenic agents, diabetes, acromegaly |
| 03/03/2009 | US7498414 Comprising complementarity determining regions; recombinant host cells; fab fragments, fv fragments, diabodies, triabodies, and single domain antibodies; angiogenesis inhibitors; antitumor, antiproliferative, and anticarcinogenic agents; gene expression |
| 03/03/2009 | US7498406 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 03/03/2009 | US7498358 Human ADAM-10 inhibitors |
| 03/03/2009 | US7498340 Topoisomerase I inhibitors; improved stability, water solubility, toxicity; anticancer agents; camptothecins bearing an oxime group in position 7; 7-tert-butoxyiminomethyl-20-O-(4-trimethyl-ammonium-3-hydroxy)butanoyl-camptothecin bromide; glioma |
| 03/03/2009 | US7498335 Method of producing an antiangiogenic or vascular permeability reducing effect |
| 03/03/2009 | US7498334 Pyrrolopyrimidines as phosphodiesterase VII inhibitors |
| 03/03/2009 | US7498323 Spiro-piperidine compounds and medicinal use thereof |
| 03/03/2009 | US7498320 Cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs |
| 03/03/2009 | US7498313 Large circular target-specific antisense nucleic acid compounds |
| 03/03/2009 | US7498306 E4 or F4 and Bcl-2 peptides of small dimension (less than 30 amino acids) that bind a PP2A holoenzyme or one of its sub-units, particularly useful as anticancer, antiviral and antiparasitic agents |
| 03/03/2009 | US7498302 Analogues of rachelmycin and the duocarmycins that are potent cytotoxins containing a benzodipyrrole or naphthopyrrole ring; anticancer agents |
| 03/03/2009 | US7498157 Polypeptide crystal having a polyhistidine tag added to the C-terminal end; effectors; drug screening for enzyme inhibitors; multiple sclerosis, diabetes, Grave's disease, rheumatic arthritis, AIDS, cancer, immunomodulators |
| 03/03/2009 | US7498149 Proteins having effects of controlling cell migration and cell death |
| 03/03/2009 | US7498147 Modulating the activity of one or more elements in the complement/lipid pathway |
| 03/03/2009 | US7498143 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 03/03/2009 | US7498129 Measuring changes in level of antigen recognizable by a monoclonal antibody or antigen binding fragment; monoclonal antibody is produced by hybridoma cell line; decreased level indicates a reduced tumor; diagnosis, cell purification |
| 03/03/2009 | US7498127 Drug screening for cytostatic agent intracellular signaling inhibitor such as antitumor agents, antirheumatic agents; cardiovascular disorders; producing within a cell a fragment of heparin binding-epidermal growth factor (HB-EGF); determination of nuclear export of PLZF protein |
| 03/03/2009 | US7498046 Composition for inducing immune response comprising inverted microsomes |
| 03/03/2009 | US7498034 Imaging, diagnosis and treatment of disease |
| 03/03/2009 | US7498032 Methods for treating immune disorders or cancer with anti-CD40 antibodies |
| 03/03/2009 | US7498031 Treating sensorineural hearing loss or a vestibular disorder by administering an a PM-1antibody or an MR16-1 antibody; Meniere's disease, drug-induced inner ear disorders, viral inner ear disorders, purulent inner ear disorders, temporal bone fracture or acoustic nerve tumor |
| 03/03/2009 | CA2410880C 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
| 03/03/2009 | CA2258165C N-[4-(heteroarylmethyl)phenyl]-heteroarylamines |
| 03/03/2009 | CA2237368C 5'-deoxy-cytidine derivatives |
| 02/26/2009 | WO2009026446A2 Hdac inhibitors |
| 02/26/2009 | WO2009026408A1 Therapeutic quinoline and naphthalene derivatives |
| 02/26/2009 | WO2009026346A1 Thiazolidine compounds, and methods of making and using same |
| 02/26/2009 | WO2009026345A1 Thiazolidinone compounds, and methods of making and using same |
| 02/26/2009 | WO2009026303A1 Human c-fms antigen binding proteins |
| 02/26/2009 | WO2009026204A1 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors |
| 02/26/2009 | WO2009026107A1 Protein kinase inhibitors |
| 02/26/2009 | WO2009026075A1 Methods and compositions for treating cancers |
| 02/26/2009 | WO2009025914A2 Radiolabelled fluorobenzamide analogues, their synthesis and use in diagnostic imaging |
| 02/26/2009 | WO2009025876A2 Crystalline forms of erlotinib hcl and formulations thereof |
| 02/26/2009 | WO2009025875A1 Stable formulations of crystalline erlotinib hcl |
| 02/26/2009 | WO2009025760A2 Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof |
| 02/26/2009 | WO2009025478A1 Indole and indazole compounds as an inhibitor of cellular necrosis |